by Anthony Montanarella | Apr 16, 2026 | Company News, Product News
XGen Pharmaceuticals DJB, Inc. is excited for another new product release! Announcing the launch of Eribulin Mesylate Injection! 1 mg/2 mL (0.5 mg/mL) (NDC#39822-2080-1) Eribulin Mesylate Injection “With this launch of Eribulin Mesylate Injection, we are proud to add...